APA

Davies J. C., Wainwright C. E., Canny G. J., Chilvers M. A., Howenstine M. S., Munck A., Mainz J. G., Rodriguez S., Li H., Yen K., Ordoñez C. L. & Ahrens R. (20130730). Efficacy and safety of ivacaftor in patients aged 6 to 11 years with cystic fibrosis with a G551D mutation. : American journal of respiratory and critical care medicine.

Chicago

Davies Jane C, Wainwright Claire E, Canny Gerard J, Chilvers Mark A, Howenstine Michelle S, Munck Anne, Mainz Jochen G, Rodriguez Sally, Li Haihong, Yen Karl, Ordoñez Claudia L and Ahrens Richard. 20130730. Efficacy and safety of ivacaftor in patients aged 6 to 11 years with cystic fibrosis with a G551D mutation. : American journal of respiratory and critical care medicine.

Harvard

Davies J. C., Wainwright C. E., Canny G. J., Chilvers M. A., Howenstine M. S., Munck A., Mainz J. G., Rodriguez S., Li H., Yen K., Ordoñez C. L. and Ahrens R. (20130730). Efficacy and safety of ivacaftor in patients aged 6 to 11 years with cystic fibrosis with a G551D mutation. : American journal of respiratory and critical care medicine.

MLA

Davies Jane C, Wainwright Claire E, Canny Gerard J, Chilvers Mark A, Howenstine Michelle S, Munck Anne, Mainz Jochen G, Rodriguez Sally, Li Haihong, Yen Karl, Ordoñez Claudia L and Ahrens Richard. Efficacy and safety of ivacaftor in patients aged 6 to 11 years with cystic fibrosis with a G551D mutation. : American journal of respiratory and critical care medicine. 20130730.